In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein–Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin

Although several infectious agents and particularly Epstein–Barr virus (EBV) have been suspected to be involved in aetiology of rheumatoid arthritis (RA), their role still remains elusive. Almost 80 % of RA sera contain antibodies to citrullinated proteins/peptides. Among them, the autoantibodies to...

Full description

Saved in:
Bibliographic Details
Published in:Immunologic research 2015-02, Vol.61 (1-2), p.117-125
Main Authors: Cornillet, M., Verrouil, E., Cantagrel, A., Serre, G., Nogueira, L.
Format: Article
Language:English
Subjects:
Allergology
Antibodies - immunology
Arthritis, Rheumatoid - immunology
Biomedical and Life Sciences
Biomedicine
Case-Control Studies
Cross Reactions - immunology
Diagnostics and Environmental Factors
Enzyme-Linked Immunosorbent Assay
Epstein-Barr Virus Nuclear Antigens - chemistry
Epstein-Barr Virus Nuclear Antigens - immunology
Fibrin - chemistry
Fibrin - immunology
Human health and pathology
Humans
Immunodominant Epitopes - immunology
Immunology
Infectious diseases
Internal Medicine
Life Sciences
Medicine/Public Health
Peptides - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although several infectious agents and particularly Epstein–Barr virus (EBV) have been suspected to be involved in aetiology of rheumatoid arthritis (RA), their role still remains elusive. Almost 80 % of RA sera contain antibodies to citrullinated proteins/peptides. Among them, the autoantibodies to citrullinated human fibrinogen (AhFibA) are composed of two non-cross-reactive subsets directed to immunodominant epitopes borne by the α36-50Cit and β60-74Cit fibrin peptides. RA sera also contain antibodies towards the citrullinated EBNA35-58Cit peptide derived from the EBNA-1 protein of EBV. Here, using a large cohort of RA patients and controls, we showed that for a diagnostic specificity of 98.5 %, 47 % of the AhFibA-positive patients were anti-EBNA35-58Cit-positive and that almost all (98.5 %) the anti-EBNA35-58Cit-positive were AhFibA-positive, whereas 86 % were anti-β60-74Cit-positive and only 43 % anti-α36-50Cit-positive. AhFibA, anti-EBNA35-58Cit- and anti-β60-74Cit-antibody titres were significantly correlated. Competition assays showed that anti-EBNA35-58Cit antibodies are highly cross-reactive with the β60-74Cit peptide. The demonstration that a citrullinated peptide derived from the EBNA-1 protein of EBV presents a molecular mimicry with human citrullinated fibrin constitutes an additional argument for a possible role of EBV in RA aetiopathogeny.
ISSN:0257-277X
1559-0755
DOI:10.1007/s12026-014-8584-2